Cargando…
Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023
We estimated influenza vaccine effectiveness (IVE) in preventing outpatient and hospitalized cases in the 2022–2023 season. A test-negative design included a representative sample of outpatients and all hospitalized patients with influenza-like illness (ILI) from October 2022 to May 2023 in Navarre,...
Autores principales: | Martínez-Baz, Iván, Fernández-Huerta, Miguel, Navascués, Ana, Pozo, Francisco, Trobajo-Sanmartín, Camino, Casado, Itziar, Echeverria, Aitziber, Ezpeleta, Carmen, Castilla, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534462/ https://www.ncbi.nlm.nih.gov/pubmed/37766154 http://dx.doi.org/10.3390/vaccines11091478 |
Ejemplares similares
-
Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022) -
Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
por: Castilla, Jesús, et al.
Publicado: (2022) -
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018) -
Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination
por: Martínez-Baz, Iván, et al.
Publicado: (2021) -
Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16
por: Castilla, Jesús, et al.
Publicado: (2018)